MERTK and neoplasm: As reported by Bosurgi et al., MerTK-deficient mice resulted in increased pro-inflammatory cytokine secretion and decreased AC clearance in colon cancer models, ultimately sponsoring a tumour-promoting tumour microenvironment (TME) [28,29].